Farringdon Capital, Ltd. 10x Genomics, Inc. Transaction History
Farringdon Capital, Ltd.
- $242 Billion
- Q4 2024
A detailed history of Farringdon Capital, Ltd. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 14,767 shares of TXG stock, worth $181,929. This represents 0.09% of its overall portfolio holdings.
Number of Shares
14,767Holding current value
$181,929% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
294Shares Held
95.4MCall Options Held
242KPut Options Held
116K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$147 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$135 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$78.8 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.5.71MShares$70.4 Million0.92% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.71MShares$70.4 Million0.06% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.17B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...